Vasopressor therapy in atypical antipsychotic overdose

被引:3
|
作者
Lorente, V. Pillay-Fuentes [1 ]
van Rensburg, R. [1 ]
Cloete, D. A. [2 ]
Lahri, S. [2 ]
Decloedt, E. H. [1 ]
机构
[1] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Med, Div Clin Pharmacol, Cape Town, South Africa
[2] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Family Med, Div Emergency Med, Cape Town, South Africa
来源
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2020年 / 110卷 / 10期
关键词
TRICYCLIC ANTIDEPRESSANT OVERDOSE; CRITICAL-CARE; QUETIAPINE OVERDOSE; DRUG OVERDOSE; UNITS;
D O I
10.7196/SAMJ.2020.v110i10.14771
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypotension is a common presentation following an overdose of quetiapine. Adrenaline is often used as the vasopressor of choice for hypotension not responding to intravenous fluids. We present a case of quetiapine overdose with hypotension unresponsive to high-dose adrenaline. The patient was commenced on noradrenaline and made a full recovery. We highlight learning points about vasopressor therapy for atypical antipsychotic overdose. Quetiapine-induced hypotension is thought to be mediated by alpha(1)-receptor antagonism. Adrenaline is unlikely to improve blood pressure, as it is an agonist at both alpha- and beta-receptors. Alpha-2- and beta(2)-agonism can reduce sympathetic outflow and cause vasodilation, respectively, further exacerbating the hypotension. Noradrenaline is the preferred vasopressor of choice for hypotension caused by quetiapine overdose, as it has less affinity for alpha(2)- and beta(2)-receptors, but maintains alpha(1)-receptor agonism. Drugs with a similar mechanism of inducing hypotension should also be treated with noradrenaline as the vasopressor of choice.
引用
收藏
页码:1003 / 1005
页数:3
相关论文
共 50 条
  • [1] Atypical antipsychotic overdose in the pediatric population
    Catalano, G
    Catalano, MC
    Nunez, CY
    Walker, SC
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (04) : 425 - 434
  • [2] Vasopressor requirements in antipsychotic overdose, a poison center observational study
    Tobarran, Natasha
    Kershner, Emily
    Michienzi, Avery
    Charlton, Nathan
    Rose, S. Rutherfoord
    Best, Albert
    Wills, Brandon
    Cumpston, Kirk
    CLINICAL TOXICOLOGY, 2021, 59 (11) : 1108 - 1108
  • [3] Vasopressor Requirements in Antipsychotic Overdose A Poison Center Observational Study
    Tobarran, Natasha
    Kershner, Emily K.
    Cumpston, Kirk L.
    Chambers, Andrew
    Michienzi, Avery
    Rose, S. Rutherfoord
    Charlton, Nathan
    Wills, Brandon K.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2025, 45 (02) : 92 - 95
  • [4] EFFICIENCY OF ATYPICAL ANTIPSYCHOTIC IN THERAPY SCHIZOPHRENIA
    Ivic, B. M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [5] A systematic review of cardiovascular effects after atypical antipsychotic medication overdose
    Tan, Hock Heng
    Hoppe, Jason
    Heard, Kennon
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2009, 27 (05): : 607 - 616
  • [6] Does overdose of atypical antipsychotic medications cause ventricular arrhythmias? A systematic review
    Tan, H. H.
    Hoppe, J.
    Heard, K.
    CLINICAL TOXICOLOGY, 2007, 45 (06): : 621 - 621
  • [7] Add-on-Therapy with atypical antipsychotic.
    Ameri, Abdol A.
    PSYCHOPHARMAKOTHERAPIE, 2011, 18 (01): : 40 - 41
  • [8] Less PONV in Patients on atypical antipsychotic Therapy
    Lampl, Benedikt
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2019, 54 (06):
  • [9] Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
    DuBois, D
    CURRENT OPINION IN PEDIATRICS, 2005, 17 (02) : 227 - 233
  • [10] Paralytic ileus associated with combined atypical antipsychotic therapy
    Dome, Peter
    Teleki, Zsofia
    Kotanyi, Reka
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (02): : 557 - 560